Zuranolone to face challenges in Japan’s MDD market despite demonstrating rapid onset of action:… EP News Bureau Oct 22, 2024 Shionogi's zuranolone faces hurdles in Japan's MDD market, balancing rapid efficacy against safety concerns and established…
